The European Medicines Agency (EMA) and the European Commission
have published additional information material on biosimilar medicines, as part
of their ongoing collaboration to improve understanding of biosimilars across
the European Union (EU). A biosimilar is biological medicine that is highly
similar in all essential aspects to a 'reference' biological medicine already
authorised.
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology
